Difference between revisions of "Andrew Philip Witty"
Jump to navigation
Jump to search
(Created page with "{{person |wikipedia= |residence=UK |companieshouse=https://beta.companieshouse.gov.uk/officers/uFGmA0Cu3MOW-amtHcftGj6jlLo/appointments |image=Andrew_Witty_in_2015.jpg |image_...") |
|||
Line 4: | Line 4: | ||
|companieshouse=https://beta.companieshouse.gov.uk/officers/uFGmA0Cu3MOW-amtHcftGj6jlLo/appointments | |companieshouse=https://beta.companieshouse.gov.uk/officers/uFGmA0Cu3MOW-amtHcftGj6jlLo/appointments | ||
|image=Andrew_Witty_in_2015.jpg | |image=Andrew_Witty_in_2015.jpg | ||
− | |image_width= | + | |image_width=400px |
|image_caption=At [[Chatham House]] in 2015 | |image_caption=At [[Chatham House]] in 2015 | ||
|nationality=UK | |nationality=UK | ||
Line 11: | Line 11: | ||
|death_date= | |death_date= | ||
|death_place= | |death_place= | ||
− | |constitutes=businessman | + | |constitutes=businessman |
|employment={{job | |employment={{job | ||
|title=GlaxoSmithKline/CEO | |title=GlaxoSmithKline/CEO | ||
Line 31: | Line 31: | ||
In April 2020, Witty began a leave of absence from Optum to assist the [[WHO]] in developing a [[vaccination for COVID-19]]. | In April 2020, Witty began a leave of absence from Optum to assist the [[WHO]] in developing a [[vaccination for COVID-19]]. | ||
+ | |||
+ | ==Awards== | ||
+ | Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry. | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
{{Stub}} | {{Stub}} |
Revision as of 15:27, 17 April 2020
Andrew Philip Witty (businessman) | |
---|---|
At Chatham House in 2015 | |
Born | August 1964 |
Residence | UK |
Nationality | UK |
Sir Andrew Philip Witty is a big pharma executive involved in organising the response to COVID-19.
In April 2020, Witty began a leave of absence from Optum to assist the WHO in developing a vaccination for COVID-19.
Awards
Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry.
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.